ozurdex 700 micrograms intravitreal implant in applicator
allergan malaysia sdn bhd - dexamethasone; dexamethasone; dexamethasone -
eylea 40mg/ ml solution for intravitreal injection
bayer philippines, inc. - aflibercept - solution for intravitreal injection - 40mg/ ml
vsiqq 120 mg/ml (27.6 mg/0.23 ml) solution for injection (intravitreal)
n/a; importer: novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - brolucizumab - solution for injection (intravitreal) - 120 mg/ml (27.6 mg/0.23 ml)
vabysmo 6 mg/0.05 ml (120 mg/ml) solution for intravitreal injection
f. hoffman-la roche ltd.; importer: roche (philippines), inc.; distributor: roche (philippines), inc. - faricimab - solution for intravitreal injection - 6 mg/0.05 ml (120 mg/ml)
eylea solution for injection in prefilled syringe 2mg
bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl
eylea solution for injection in vial 2mg
bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl
vabysmo solution for injection 6mg0.05ml
roche singapore pte. ltd. - faricimab - injection, solution - faricimab 6.00mg/0.05ml
beovu brolucizumab (rbe) 120 mg/ml solution for injection in vial
novartis pharmaceuticals australia pty ltd - brolucizumab, quantity: 120 mg/ml - injection, solution - excipient ingredients: sodium citrate; sucrose; polysorbate 80; water for injections - beovu is indicated for the treatment of: - neovascular (wet) age-related macular degeneration (amd). - diabetic macular oedema (dme)
ozurdex implant
abbvie corporation - dexamethasone - implant - 0.7mg - dexamethasone 0.7mg - corticosteroids
byooviz solution
samsung bioepis co., ltd - ranibizumab - solution - 10mg - ranibizumab 10mg